期刊文献+

CHA2DS2-VASc评分与非瓣膜性心房颤动并缺血性脑卒中患者预后的关系 被引量:6

Relationship between CHA2DS2-VASc score and short-term prognosis of aged patients with nonvalvular atrial fibrillation complicated ischemic cerebral stroke
下载PDF
导出
摘要 目的:探讨非瓣膜病房颤卒中风险评分(CHA2DS2-VASc)与老年非瓣膜性心房颤动(NVAF)合并缺血性脑卒中(ICS)患者短期预后的关系。方法:入选我院2011年6月到2013年8月住院的206例老年NVAF合并ICS患者,应用CHA2DS2-VASc进行评分,分为低危组(24例,0分)、中危组(78例,1分)和高危组(104例,2-9分)。在发病后3个月时,采用改良Rankin量表(mRS)评定患者的预后,根据mRS得分将患者分为预后良好组(89例,0-2分)和预后不佳组(117例,3-6分)。分析患者3个月预后不佳的独立预测因素。结果:中危和高危组在年龄、高血压、糖尿病、心力衰竭、卒中、血管疾病史比例和美国国立卫生研究院卒中量表(NIHSS)评分显著高于低危组(P〈0.05或〈0.01)。与预后良好组比较,预后不佳组年龄[(72.81±7.68)岁比(81.56±8.03)岁]、高血压(58.4%比71.8%)、卒中史比例(9.0%比29.9%)、NIHSS评分[(2.97±1.42)分比(7.67±3.92)分]和CHA2DS2-VASc评分[(1.70±1.63)分比(4.03±2.53)分]显著升高,P〈0.05或〈0.01。多因素Logistic回归分析显示NIHSS评分(高危:OR=1.78,95%CI:1.27-2.56,P=0.001)、CHA2DS2-VASc评分(高危:OR=3.24,95%CI:1.32-6.98,P=0.001)和年龄(高危:OR=1.23,95%CI:1.07-1.54,P=0.01)是老年NVAF合并ICS患者3个月预后不佳的独立预测因素。结论:CHA2DS2-VASc评分与NVAF合并ICS早期病情改善有关,年龄、NIHSS评分和CHA2DS2-VASc评分是短期预后不佳的独立预测因素。 Objective:To explore the relationship between atrial fibrillation stroke risk score(CHA2DS2-VASc score)and short-term prognosis of aged patients with nonvalvular atrial fibrillation(NVAF)complicated ischemic cerebral stroke(ICS).Methods:A total of 206 aged NVAF+ICS patients who hospitalized in our hosipital from Jun 2011 to Aug 2013 were selected.CHA2DS2-VASc score was used to perform stroke risk stratification,and patients were divided into low risk group(n=24,0score),medium risk group(n=78,1score)and high risk group(n=104,2-9scores).Modified Rankin scale(mRS)was used to assess patients' prognosis on three months after onset.According to mRS score,patients were divided into good prognosis group(n=89,0-2scores)and poor prognosis group(n=117,3-6scores).Independent predictors for poor prognosis in three months were analyzed.Results:Compared with low risk group,there were significant rise in age,percentages of hypertension,diabetes mellitus(DM),heart failure,stroke and vascular disease history,scores of United States national institutes of health stroke score(NIHSS)in medium and high risk groups(P〈0.05or〈0.01).Compared with good prognosis group,there were significant rise in age[(72.81±7.68)years vs.(81.56±8.03)years],percentages of hypertension(58.4% vs.71.8%)and stroke history(9.0% vs.29.9%),scores of NIHSS [(2.97±1.42)scores vs.(7.67±3.92)scores]and CHA2DS2-VASc[(1.70±1.63)scores vs.(4.03±2.53)scores]in poor prognosis group,P〈0.05or〈0.01.Multi-factor Logistic regression analysis indicated NIHSS score(high risk:OR=1.78,95%CI:1.27-2.56,P =0.001),CHA2DS2-VASc scores(high risk:OR=3.24,95%CI:1.32-6.98,P=0.001)and age(high risk:OR=1.23,95%CI:1.07-1.54,P=0.01)were independent predictors for poor prognosis on three months in aged NVAF +ICS patients.Conclusion:CHA2DS2-VASc score is related to early improvement of patients with NVAF + ICS;age,scores of NIHSS and CHA2DS2-VASc are independent predictors for poor short-term prognosis.
出处 《心血管康复医学杂志》 CAS 2016年第2期136-141,共6页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 心房颤动 卒中 预后 老年人 Atrial fibrillation Stroke Prognosis Aged
  • 相关文献

参考文献19

  • 1Lip, Godtfredsen GY. Cardiac arrhythmias: a clinical ap- proach [M]. Edinburgh~ Mosby, 2003:3 - 24.
  • 2宋笑凯,王文静,李淮玉,任明山,卢节平,吴燕.CHA2DS2-VASc评分法对非瓣膜病性心房纤颤患者继发脑梗死的风险评估作用[J].临床神经病学杂志,2013,26(3):183-186. 被引量:26
  • 3李瑾,郭豫涛,王春江.老年心房颤动患者年龄相关的卒中/出血风险及临床特点[J].中华心血管病杂志,2013,41(11):927-930. 被引量:17
  • 4Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in at- rial fibrillation using a novel risk factor- based approach: the euro heart survey on atrial fibrillation [J]. Chest, 2010, 137 (2): 263-272.
  • 5Camm AJ,Kirchhof P,Lip GY,et al. Guidelines for the manage- ment of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ECS) [J]. Eur Hear J,2010,31(19) :2369 - 2429.
  • 6中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国全科医学,2011,14(35):4013-4017. 被引量:1262
  • 7January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/ HRS guideline for the management of patients with atrial fibril- lation, executive summary, a report of the American College of Cardiology/American Heart Association Task Force on prac- tice guidelines and the Heart Rhythm Society [J]. Circulation, 2014, 130 (23): 2071-2014.
  • 8王志敬,张立娟,周茂峰.心房颤动抗栓治疗新进展[J].现代医学,2011,39(6):747-750. 被引量:10
  • 9Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke, results from the National Registry of Atrial Fibrillation[J]. JAMA, 2001, 285 (22): 2864-2870.
  • 10刘骅,刘启明.CHADS2评分与CHA2DS2-VASC评分孰优孰劣[J].中外医疗,2014,33(6):196-198. 被引量:11

二级参考文献60

  • 1中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国医学前沿杂志(电子版),2010,2(4):50-59. 被引量:1847
  • 2周自强,胡大一,陈捷,张仁汉,李奎宝,赵秀丽.中国心房颤动现状的流行病学研究[J].中华内科杂志,2004,43(7):491-494. 被引量:1401
  • 3黄从新,马长生,杨延宗,黄德嘉,张澍,江洪,杨新春,吴书林,马坚,刘少稳,李莉,曹克将,王方正,陈新.心房颤动:目前的认识和治疗建议(二)[J].中华心律失常学杂志,2006,10(3):167-197. 被引量:269
  • 4FUSTER V, RYDEN L E, CANNOM D S, et al. ACC/AHA/ ESC 2006 guidelines for the management of patients with artri- al fibrillation : a report of the American College of Cardiology/ American Heart Association task force on practice guidelines and the European Society of Cardiology Committee for practice guidelines(writing committee to revise the 2001 guidelines for the management of patients with artrial fibrillation ) : developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society [ J]. Circulation, 2006, 114(7) :e257-354.
  • 5WADELIUS M, CHEN L Y, ER1KSSON N, et al. Association of warfarin dose with genes involved in its action and metabolism[ J]. Hum Genet ,2007,121 ( 1 ) :23-24.
  • 6Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials [ J ]. Arch Intern Med, 1994, 154 ( 13 ) : 1449-1457.
  • 7CONNOLLY S J, POGUE J, HART R G, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation[J]. N Engl J Med, 2009,360 ( 20 ) :2066- 2078.
  • 8CONNOLLY S J, POGUE J, HART R G, et al. Clopidogrel pius aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events( ACTIVE W) : a randominsed controlled trial [ J ]. Lancet, 2006,367 ( 9526 ) : 1903-1912.
  • 9SINGER D E, ALBERS G W, DALEN J E, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians evidence-based clinical practice guidelines (8th Edition) [ J ]. Chest,2008,133 (6 Suppl) :546S-592S.
  • 10KING HI S B, SMITH S C Jr, HIRSHFELD J W Jr, et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention : a report of the Americam College of Cardiology/American Heart Association task force on practice guidelines [ J ]. J Am Coll Cardiol, 2008,51 (2) : 172- 209.

共引文献1315

同被引文献67

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部